Recall Radar
All recalls › Medicine & devices

MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.

CGMP Deviations

Class II Medicine & devices FDA September 9, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Baxter Healthcare Corporation — Deerfield, IL
Severity
Class II — moderate
Reported
September 9, 2026
Quantity
N/A
Recall number
D-0806-2026
Status
Ongoing
Source
FDA

Where it went

US Nationwide; Puerto Rico; and Chile.

Other medicine & devices recalls

See every current recall on the live dashboard →